AGP Executive Report
Last update: an hour agoFederal–State Tension: DOJ’s move to reclassify some medical marijuana from Schedule I to Schedule III still won’t make weed fully legal federally, leaving states to carry the policy load and patients stuck in a patchwork. Workplace & Public Health: New research suggests evening cannabis may boost next-day work engagement for some people, while separate coverage keeps spotlighting impairment and youth vaping risks. Regulation Watch: Missouri regulators are preparing the final microbusiness lottery with tighter rules aimed at cutting predatory deals. Global Controls: Thailand’s stricter “medical-only” framework is rolling out, but enforcement looks uneven on the ground. Medical Science: Alzheimer’s researchers report progress by leaning on the brain’s own waste-cleaning system, and a small trial links inflammation-targeting therapy to improved depression outcomes. Market Noise: A fresh CBD market growth forecast keeps circulating, but today’s real signal is policy and enforcement—still the biggest driver.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
